Effect of <i>CTLA4</i> gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation
Background. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is being widely applied as a therapy for hematological malignancies. The long-term outcome of allo-HSCT depends directly on the ability of cytotoxic T-lymphocytes to recognize and eliminate the residual tumor. CTLA-4 is one o...
Saved in:
| Main Authors: | D. S. Romaniuk, A. A. Khmelevskaya, M. Yu. Drokov, N. N. Popova, V. A. Vasilieva, L. A. Kuzmina, G. A. Efimov, E. N. Parovichnikova, V. G. Savchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-04-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/337 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01) -
The late outcomes of syngeneic hematopoietic stem cell transplantation in patients with blood disorders
by: A. A. Dmitrova, et al.
Published: (2022-11-01) -
Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation
by: M. I. Akhmedov, et al.
Published: (2022-01-01) -
Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01) -
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-08-01)